Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy
Go back to Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy| (NASDAQ: CYCN) | Delayed: 3.89 -0.18 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $ | |||
| Open | $4.07 | 52 Week Low | $ | |||
| Day High | $4.29 | P/E | N/A | |||
| Day Low | $3.78 | EPS | $ | |||
| Volume | 65,749 | |||||

